Prevalence of risk-drinking in critically ill patients, screened with carbohydrate-deficient transferrin and AUDIT-C

Eliisa Uljas1, Ville Jalkanen2, Anne Kuitunen2

  • 1Division of Intensive Care, Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Insights

One in three ICU patients exhibit risky alcohol consumption, as indicated by AUDIT-C scores, and one in four show elevated carbohydrate-deficient transferrin (%CDT). Relying on a single screening method may not reliably detect high-risk alcohol use in this population.

Area of Science:

  • Critical Care Medicine
  • Clinical Biochemistry
  • Addiction Medicine

Background:

  • Up to one-third of intensive care unit (ICU) admissions are linked to alcohol use.
  • Routine screening for alcohol consumption is not standard practice in ICUs.
  • Identifying alcohol use is crucial due to its impact on patient outcomes.

Purpose of the Study:

  • To determine the prevalence of elevated carbohydrate-deficient transferrin (%CDT) and Alcohol Use Disorders Identification Test, Consumption (AUDIT-C) scores in ICU patients.
  • To investigate the association between these alcohol use markers and patient outcomes.

Main Methods:

  • Retrospective analysis of clinical and laboratory data from 2532 adult ICU patients over 21 months.
  • Measured %CDT and AUDIT-C scores upon ICU admission.
  • Used logistic regression to analyze the association of %CDT and AUDIT-C with short- and long-term mortality.

Main Results:

  • %CDT was elevated in 23.7% of patients, while 33% had risk-level AUDIT-C scores.
  • Patients with risk-level AUDIT-C scores were significantly younger.
  • Elevated %CDT correlated with higher illness severity, and AUDIT-C independently predicted long-term mortality.

Conclusions:

  • A significant proportion of ICU patients exhibit markers of risky alcohol consumption.
  • Prevalence rates differ between %CDT and AUDIT-C, suggesting limitations of single screening methods.
  • Combined use of biomarkers and screening tools may be necessary for reliable detection of alcohol use disorders in ICU settings.